Vanguard Group
CRVO icon

Vanguard Group’s CervoMed CRVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.14M Sell
340,018
-38,644
-10% -$243K ﹤0.01% 3517
2025
Q1
$3.46M Sell
378,662
-4,825
-1% -$44.1K ﹤0.01% 3303
2024
Q4
$897K Sell
383,487
-16,812
-4% -$39.3K ﹤0.01% 3798
2024
Q3
$5.84M Sell
400,299
-8,476
-2% -$124K ﹤0.01% 3208
2024
Q2
$7M Buy
408,775
+381,483
+1,398% +$6.53M ﹤0.01% 3099
2024
Q1
$636K Buy
27,292
+7,376
+37% +$172K ﹤0.01% 3955
2023
Q4
$152K Hold
19,916
﹤0.01% 4255
2023
Q3
$92K Sell
19,916
-46,316
-70% -$214K ﹤0.01% 4357
2023
Q2
$221K Sell
66,232
-6,531
-9% -$21.8K ﹤0.01% 4297
2023
Q1
$302K Hold
72,763
﹤0.01% 4248
2022
Q4
$368K Buy
72,763
+42
+0.1% +$212 ﹤0.01% 4180
2022
Q3
$389K Sell
72,721
-7,249
-9% -$38.8K ﹤0.01% 4284
2022
Q2
$534K Sell
79,970
-3,918,662
-98% -$26.2M ﹤0.01% 4275
2022
Q1
$999K Sell
3,998,632
-595,757
-13% -$149K ﹤0.01% 4208
2021
Q4
$1.4M Sell
4,594,389
-21,891
-0.5% -$6.68K ﹤0.01% 4166
2021
Q3
$2.35M Buy
4,616,280
+9,313
+0.2% +$4.75K ﹤0.01% 4014
2021
Q2
$3.36M Buy
4,606,967
+486,095
+12% +$355K ﹤0.01% 3788
2021
Q1
$3.78M Buy
4,120,872
+3,727,642
+948% +$3.42M ﹤0.01% 3667
2020
Q4
$312K Buy
393,230
+40,949
+12% +$32.5K ﹤0.01% 4032
2020
Q3
$297K Buy
352,281
+34,272
+11% +$28.9K ﹤0.01% 3904
2020
Q2
$310K Buy
318,009
+290,666
+1,063% +$283K ﹤0.01% 3861
2020
Q1
$9K Hold
27,343
﹤0.01% 4071
2019
Q4
$13K Sell
27,343
-45,790
-63% -$21.8K ﹤0.01% 4108
2019
Q3
$135K Buy
73,133
+33,709
+86% +$62.2K ﹤0.01% 4002
2019
Q2
$112K Sell
39,424
-9,800
-20% -$27.8K ﹤0.01% 4043
2019
Q1
$183K Buy
49,224
+5,340
+12% +$19.9K ﹤0.01% 3939
2018
Q4
$87K Sell
43,884
-850,848
-95% -$1.69M ﹤0.01% 4011
2018
Q3
$386K Sell
894,732
-25,383
-3% -$11K ﹤0.01% 3893
2018
Q2
$421K Buy
920,115
+15,300
+2% +$7K ﹤0.01% 3849
2018
Q1
$494K Buy
904,815
+676,172
+296% +$369K ﹤0.01% 3789
2017
Q4
$272K Buy
228,643
+99,559
+77% +$118K ﹤0.01% 3875
2017
Q3
$214K Buy
129,084
+22,902
+22% +$38K ﹤0.01% 3902
2017
Q2
$247K Buy
106,182
+38,471
+57% +$89.5K ﹤0.01% 3864
2017
Q1
$270K Buy
+67,711
New +$270K ﹤0.01% 3856